bromocriptine has been researched along with Compensatory Hyperinsulinemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, R; Lv, J; Pan, M; Pan, Y; Zhang, Y | 1 |
| Hayashi, K; Iigaya, K; Kumagai, H; Onami, T; Saruta, T | 1 |
| Cincotta, AH; Meier, AH | 1 |
| Chen, YD; Cincotta, AH; Jones, CN; Kamath, V; Reaven, GM; Varasteh, BB; Yip, JC | 1 |
| Cincotta, AH; Liang, Y | 1 |
| Landgraf, R; Landgraf-Leurs, MM; Scriba, PC; von Werder, K | 1 |
| Cincotta, AH; Meier, AH; Schiller, BC | 1 |
1 review(s) available for bromocriptine and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
[Hypertension in acromegaly].
Topics: Acromegaly; Blood Pressure; Bromocriptine; Circadian Rhythm; Human Growth Hormone; Humans; Hyperinsulinism; Hypertension; Insulin Resistance; Insulin-Like Growth Factor I; Kidney Tubules, Proximal; Octreotide; Plasma Volume; Sodium; Stroke; Sympathetic Nervous System; Vascular Resistance | 2004 |
1 trial(s) available for bromocriptine and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Bromocriptine; Cholesterol; Dopamine Agonists; Fasting; Fatty Acids, Nonesterified; Female; Humans; Hyperinsulinism; Insulin; Lipid Metabolism; Lipids; Lipoproteins; Middle Aged; Obesity; Postprandial Period; Prolactin; Triglycerides | 1997 |
5 other study(ies) available for bromocriptine and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Pituitary Prolactinoma Imaged by 99mTc-Sestamibi SPECT/CT in a Multiple Endocrine Neoplasia Type 1 Patient.
Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hypercalcemia; Hyperinsulinism; Hyperparathyroidism, Primary; Hyperprolactinemia; Magnetic Resonance Imaging; Multiple Endocrine Neoplasia Type 1; Parathyroid Glands; Parathyroidectomy; Pituitary Neoplasms; Prolactinoma; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2016 |
Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus).
Topics: Animals; Blood Glucose; Bromocriptine; Circadian Rhythm; Cricetinae; Disease Models, Animal; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucose; Hormone Antagonists; Hyperinsulinism; Insulin; Insulin Resistance; Lipolysis; Liver; Mesocricetus; Obesity; Oxidation-Reduction; Seasons | 1995 |
Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Agonists; Animals; Blood Glucose; Bromocriptine; Dopamine Agonists; Female; Glucagon; Glucose Clamp Technique; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Secretion; Mice; Mice, Inbred C57BL; Mice, Obese; Norepinephrine; Random Allocation | 2001 |
[Therapy of the diabetic metabolic condition in hyperprolactinemias and acromegaly].
Topics: Acromegaly; Blood Glucose; Bromocriptine; Female; Humans; Hyperinsulinism; Male; Prolactin | 1976 |
Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Bromocriptine; Cricetinae; Female; Glucose Tolerance Test; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Mesocricetus; Obesity; Seasons | 1991 |